Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Caputo

Showing results (501-510 of 510) with videos related to

Pageof 51
Sort By:
You have reached the last page of results.This site can display upto 510 results.
The Prostate|April 28, 2023
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamideAlbert Jang, Sree M Lanka, Minqi Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in <i>AR</i> -altered lethal prostate cancerPradeep S Chauhan, Irfan Alahi, Savar Sinha, et al.
Gynecologic Oncology|January 24, 2020
Low-grade serous ovarian cancer: State of the scienceBrian Slomovitz, Charlie Gourley, Mark S Carey, et al.
JCI Insight|December 2, 2021
Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk childrenOren Gordon, Mary Katherine Brosnan, Steve Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2024
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate CancerPradeep S Chauhan, Irfan Alahi, Savar Sinha, et al.
JCI Insight|February 1, 2022
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infectionHan-Sol Park, Janna R Shapiro, Ioannis Sitaras, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled TrialShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 51

Showing results (501-510 of 510) with videos related to

Sort By:
Pageof 51
You have reached the last page of results.This site can display upto 510 results.
The Prostate|April 28, 2023
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamideAlbert Jang, Sree M Lanka, Minqi Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in <i>AR</i> -altered lethal prostate cancerPradeep S Chauhan, Irfan Alahi, Savar Sinha, et al.
Gynecologic Oncology|January 24, 2020
Low-grade serous ovarian cancer: State of the scienceBrian Slomovitz, Charlie Gourley, Mark S Carey, et al.
JCI Insight|December 2, 2021
Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk childrenOren Gordon, Mary Katherine Brosnan, Steve Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2024
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate CancerPradeep S Chauhan, Irfan Alahi, Savar Sinha, et al.
JCI Insight|February 1, 2022
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infectionHan-Sol Park, Janna R Shapiro, Ioannis Sitaras, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled TrialShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 51